Regeneron Pharmaceuticals
REGN
#145
Rank
$105.64 B
Marketcap
$962.49
Share price
-0.39%
Change (1 day)
17.32%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): $37.36

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $37.36. In 2022 the company made an earnings per share (EPS) of $40.52 a decrease over its 2021 EPS that were of $76.45.

EPS history for Regeneron Pharmaceuticals from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$37.36-7.8%
2022$40.52-47%
2021$76.45133.36%
2020$32.7669.13%
2019$19.37-14.44%
2018$22.64100.71%
2017$11.2831.78%
2016$8.5638.96%
2015$6.1672.55%
2014$3.57-17.55%
2013$4.33-44.98%
2012$7.87-422.54%
2011-$2.4492.13%
2010-$1.2749.41%
2009-$0.85-15.84%
2008-$1.01-36.88%
2007-$1.60-9.6%
2006-$1.774.12%
2005-$1.70-323.68%
2004$0.76-135.51%
2003-$2.14-24.38%
2002-$2.8356.35%
2001-$1.81

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$14.09-62.30%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.74-89.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$14.15-62.13%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.18-91.49%๐Ÿ‡ซ๐Ÿ‡ท France
$18.46-50.59%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.11-111.00%๐Ÿ‡บ๐Ÿ‡ธ USA